ARTICLE | Company News
Advanced Cancer Therapeutics, University of Louisville deal
March 10, 2008 7:00 AM UTC
Advanced Cancer Therapeutics received an exclusive, worldwide license from the university to develop and market 3PO and related compounds to treat cancer. The inhibitor of 6-phosphofructo-2-kinase/fru...